Former Amgen Exec Sersch Joins Mustang Bio as Chief Medical Officer

Frank Vinluan

Frank Vinluan

October 15th, 2018

Xconomy New York —

Mustang Bio (NASDAQ: MBIO) has appointed Martina Sersch to serve as chief medical officer. Sersch comes to New York-based Mustang from Amgen (NASDAQ: AMGN), where she was executive director. Mustang is developing cell therapies to treat cancer and gene therapies to treat rare, genetic disorders.

Frank Vinluan is editor of Xconomy Raleigh-Durham, based in Research Triangle Park. You can reach him at fvinluan [at] xconomy.com Follow @frankvinluan

Trending on Xconomy

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Protecting Your Science: Storage & Monitoring for Life Science Organizations
Keep easily accessible, historical records to aid in root cause analysis for deviations
XiltriX

Sponsored · Whitepaper
Protecting Valuable Life Science Assets & Equipment: Monitoring Solutions
Remain compliant and ensure optimal productivity
XiltriX

Sponsored · Whitepaper
Leveraging Predictive Analytics for Pharmaceutical Innovation
Read Now
Xiltrix

From Our Advertisers

Wisconsin helps biotech company raise $20 million
See how TAI Diagnostics achieved accelerated growth
Wisconsin Economic Development Corporation

Tweets from https://twitter.com/Xconomy/lists/lifesci